Document:

Exhibit 10.18

Exhibit 10.18

Robertson Technologies Licensing, LLC and Companies On Text

License Agreement Domestic USA Market

This License Agreement (this “Agreement”) is made effective as of 04/28/2010 between Robertson
Technologies Licensing, LLC, a Nevada limited liability company (the “Licensor”), of 4215 Fashion
Square Blvd, Suite 3, Saginaw, Michigan 48603 and its affiliates, and Companies On Text, LLC
(LICENSEE — the “Licensee”) of 30135 Summit Dr., Ste. 201, Farmington Hills, Michigan 48334.

In the Agreement, the party who is granting the right to sell/market its products/services will be
referred to as “ Licensor”, and the party who is receiving the right to sell/market the
products/services will be referred to as “LICENSEE “. It must be noted that LICENSEE is a
Distribution partner of Aversien Science, L.L.C. and is granted this Licensee status under the
distribution agreement of Robertson Technologies Licensing, LLC and Aversien Science, L.L.C.
Therefore, Aversien Science, L.L.C. is the company of record for compensation purposes as it
pertains to Robertson Technologies Licensing, LLC.

WHEREAS, Licensor has developed or otherwise acquired rights to certain databases, software tools
and diagnostic intellectual properties relating to medical diagnostic aids.

WHEREAS, Licensor is willing to grant a license to Licensee for use by Licensee of the subject
matter developed by Licensor, but limited to specific fields of use; and

WHEREAS, the database, software tools and diagnostic intellectual property, as limited to specific
fields of use are defined herein as “NxOpinion”. NxOpinion is the medical application using an
Inference Based Engine as proprietarily populated with medical knowledge in order to produce an
evidence-based, statistically driven diagnostic system, current treatments, medical reference, and
electronic health records; and

WHEREAS, all right, title and interest in and to NxOpinion is currently held by the Licensor; and

WHEREAS, the Licensor has agreed to license NxOpinion (with the specific fields of use described in
Exhibit A) to Licensee under the terms set forth in this Agreement.

The parties agree as follows:

I. RIGHT TO SELL. Licensor has developed a versatile, interactive knowledge management system that
can be displayed on multiple platforms and is intended to improve timeliness and accuracy of
medical diagnostics “NxOpinion”. The technology is a tool that will engage the consumers and
assist them in their quest for good health. In accordance with this Agreement, Licensor grants
Licensee the right to sell/market products/services on behalf of Licensor under the terms of this
Agreement listed below. Licenseor agrees to deliver such products/licenses necessary for the
markets identified by Licensee. Licensee agrees to devote its best efforts to the sell of the
Licensor offerings. The sales prices to the end user must be reviewed with Licensor and be in line
with the overall goals Licensor plans to bring to the marketplace.

 

 

 

II. RIGHTS AND LICENSES. Subject to the terms of this Agreement, the parties hereby grant the
following rights and licenses, pursuant to the terms and conditions of this Agreement:

	 	a.	 	Licensor grants to Licensee a revocable for cause, exclusive
license to use NxOpinion for the two identifiable markets listed here (USA).
The markets will include sale of Pre-paid card technology and sale to residents
through Multi Dwelling Units channels.

	 	b.	 	Licensee may only make NxOpinion available in the United States
through the channels listed in a. above. Licensee may request that licensor add
areas to the Territory, which Licensor may agree in its sole discretion. Any
additional agreed upon areas shall be added by amendment to this Agreement.

III. OWNERSHIP. Licensor retains all right, title and interest in and to NxOpinion and any and all
copies thereof that may be made by Licensee under this Agreement, including, without limitation,
all intellectual property rights therein. Licensee owns the tangible media it develops, if any, on
which NxOpinion is delivered and maintained.

IV. TERM.
The term of this Agreement (including all rights and licenses granted herein)
shall commence as of the Effective Date and shall continue for three (3) years based on the
Licensee meeting its performance measures listed in XVIII below.

V. RECORDS. Licensee and Licensor shall keep accurate records regarding the quantities of the
licenses that are sold. Licensor and Licensee shall develop a mutually agreeable process to
account for licenses purchased by Licensee, sold to business/public and activated by end user in
order to track the business generated, performance measures and business growth development for
future planning.

VI. TAXES

	 	a)	 	PAYROLL TAXES. Licensee shall be exclusively liable for, and shall indemnify
Licensor against such liability for, all employee payroll taxes and insurance arising
out of wages payable to persons employed by Licensee in connection with the
performance of this Agreement.

	 	b)	 	TAXES. Licensor is not liable for any taxes that Licensee is legally obligated
to pay in connection with this Agreement, and all such taxes (including but not limited
to net income or gross receipts taxes, franchise taxes, and/or property taxes) will be
the financial responsibility of Licensee.

VII. DEFAULTS. If Licensee fails to abide by the obligations of this Agreement, including the
obligation to meet performance standards and remit payments to Licensor when due, Licensor shall
have the option to cancel this Agreement by providing 45 days’ written notice to Licensee. Licensee
shall have the option of preventing the termination of this Agreement by taking corrective action
that cures the default, if such corrective action is taken prior to the end of the time period
stated in the previous sentence, and if there are no other defaults during such time period.

 

 

 

VIII. ARBITRATION. All disputes under this Agreement that cannot be resolved by the parties shall
be submitted to arbitration under the rules and regulations of the American Arbitration
Association. Either party may invoke this paragraph after providing 30 days’ written notice to the
other party. All costs of arbitration shall be divided equally between the parties. Any award may
be enforced by a court of law.

IX. REPRESENTATIONS AND WARRANTIES; LIMITATION. EXCEPT FOR ANY EXPRESS WARRANTIES SET FORTH
HEREIN, THE PARTIES MAKE NO OTHER, AND HEREBY DISCLAIM ALL OTHER WARRANTIES, WHETHER EXPRESS,
IMPLIED OR STATUTORY, WITH RESPECT TO THIS AGREEMENT, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED
WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT.

X. LIMITATION ON LIABILITY. NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INDIRECT,
INCIDENTAL, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF THIS AGREEMENT, EVEN IF SUCH PARTY HAS
BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL
PURPOSE OF ANY REMEDY.

XI. ASSIGNMENT. Neither this Agreement nor any rights hereunder may be assigned or otherwise
transferred by Licensee, in whole or in part, whether voluntary or by operation of law, including
any merger or consolidation, without the prior written consent of the Licensor, such consent not
being unreasonably withheld.

XII. TERMINATION. This Agreement may not be terminated by either party unless there are violations
of the agreement or either party is not performing its duties as outlined in this document, in
which case termination requires party to provide 45 days’ written notice to the other party.

XIII. ENTIRE AGREEMENT. This Agreement contains the entire agreement of the parties with respect to
the subject matter of this Agreement and there are no other promises or conditions in any other
agreement, whether oral or written. This Agreement supersedes any prior written or oral agreements
between the parties with respect to the subject matter of this agreement.

XIV. AMENDMENT. This Agreement may be modified or amended, if the amendment is made in writing and
is signed by both parties.

XII. SEVERABILITY. If any provision of this Agreement shall be held to be invalid or unenforceable
for any reason, the remaining provisions shall continue to be valid and enforceable. If a court
finds that any provision of this Agreement is invalid or unenforceable, but that by limiting such
provision it would become valid or enforceable, then such provision shall be deemed to be written,
construed, and enforced as so limited.

 

 

 

XIII. WAIVER OF CONTRACTUAL RIGHT. The failure of either party to enforce any provision of this
Agreement shall not be construed as a waiver or limitation of that party’s right to subsequently
enforce and compel strict compliance with every provision of this Agreement.

XIV. CONFIDENTIALITY. The parties understand and agree that certain of the information
incorporated within NxOpinion comprises information proprietary and confidential to the Licensor.
Licensee and its affiliates agree not to disclose or otherwise transfer any of NxOpinion to any
third parties, without the prior written consent of the Licensor. This obligation of
confidentiality shall continue notwithstanding termination of this Agreement for any reason
whatsoever.

XV. NOTIFICATION OF INFRINGEMENT. The Licensor and Licensee agree to notify each other, if the
notifying party becomes aware of any actual or potential infringement of any proprietary rights
associated with NxOpinion, including misappropriation or misuse of trade secrets embodied within
NxOpinion.

XVI. APPLICABLE LAW. This Agreement shall be governed by, and construed and enforced in
accordance with, the laws of the State of Michigan, without regard to the conflicts of laws
principles of such state. Any suit to enforce any provision of this Agreement, or arising out of
or based upon this Agreement, shall be brought only in the state or federal courts located in
Michigan. Each party hereby agrees that such court shall have in personam jurisdiction and venue
with respect to such party, and each party hereby submits to the in personam jurisdiction and venue
of such courts.

XVII. DISTRIBUTION RIGHTS Licensee has the right to sell Licensor solutions. Licensor has an
inherit right to make sales through its own organization and other contractual relationships as
well. However, for the purpose of distribution to two specific markets, i.e., Multi-Dwelling Units
(MDU) and Pre-Paid Cards (PPC), WHERE Licensee is granted exclusivity in this space for a period of
three (3) years provided the performance measures listed in XVIII are met. If a sale is made by
any other party in these markets utilizing the concept developed for these markets, the sale must
flow thru Licensee. Licensee will have the responsibility to facilitate the implementation of the
sales process as it does for its own direct customer. Licensee will have the right to generate its
mark up or profit margin for the customers brought by other parties, provided the price point is
consistent with the model developed and agreed upon.

XVIII. PERFORMANCE MEASURES

Licensee Measures

Year 1 — Licensee is required to purchase a minimum of one million (1,000,000) licenses from
the Licensor. Licensee is granted a program implementation period of six (6) months and
program execution period of twelve (12) months for a total of eighteen (18) months.

Year 2 — Licensee is required to purchase a minimum of one million five hundred thousand
(1,500,000) licenses from the Licensor.

Year 3 — Licensee is required to purchase a minimum of two million (2,000,000) licenses from
the Licensor.

 

 

 

Licensor Measures

Year 1 — Licensor is required to be able to provision 130,000 licenses per month

Year 2 — Licensor is required to be able to provision 140,000 licenses per month

Year 3 — is required to be able to provision 170,000 licenses per month

At the end of the first 12 months licensor will review exclusivity performance and if required take
corrective action to get back on track.

XIX. SUPPORT Licensee shall receive the support of Licensor in its efforts to market Licensor
products/licenses. Aversien Science shall facilitate the support services on behalf of Licensor.
This includes making arrangements, where deemed appropriate for appearances at key events, attend
key meetings, endorsements (letters, video, audio, media’s, etc.). Licensor shall support its
business technology systems, deliverance of technology to consumer sector, and expertise in
handling technical questions. Licensor through Aversien Science shall provide training on its
products/licenses to Licensee and its agents/contractors. Once trained, Licensee may become a
technical implementation partner with Licensor with the capabilities of training all future
contractors, agents, distribution outlets, etc. This will be reviewed and is at the sole
discretion of Aversien Science and Licensor.

Any costs incurred by Licensee in the marketing and distribution of the Licensor Technology are the
sole responsibility of Licensee. Such costs include, but are not limited to, travel,
entertainment, printing and marketing, etc. Licensee may use certain logos and corporate partner
names in marketing materials and sales presentations as agreed upon. All marketing materials
developed for the purpose of selling to customers must be pre-approved by Aversien Science, L.L.C.
and Licensor before use. Licensor, Aversien Science, and Licensee agree to establish a marketing
material response process of seven (7) days or less for material approval. All press related
material will be coordinated and approved by Licensor and Aversien Science. Licenses purchased by
Licensee are one year renewable licenses and the end user has unlimited use of the general license
for one full year from time of purchase, at which time a payment is due to continue use of the
license. Licensor technology shall be maintained and upgraded at no additional cost to Licensee
and customer will receive upgraded versions, as they are made available by Licensor.

XX. PAYMENTS.

1. License Fees. In consideration for the license and other rights granted to Licensee,
Licensee will pay Licensor license fees as follows:

	 	a.	 	Eight Dollars ($8.00) per pre-paid card distributed through
licensee. License is for a one (1) year usage and is renewable annually at the
same Eight Dollar ($8.00) rate. However, Licensor and Aversien Science reserve
the right to adjust pricing according to business and market conditions at the
end of three-year contract from date of contract execution.

	 	b.	 	Platform Setup fees of Two Hundred Fifty Thousand Dollars
($250,000) upon execution of this Agreement.

 

 

 

	 	c.	 	Advance license fees of Seven Hundred Fifty Thousand Dollars
($750,000) on or before 30 days following execution of this Agreement.

	 	d.	 	Licensor will make available Ninety Three Thousand Seven
Hundred and Fifty (93,750) licenses for use either through mobile or internet
upon completion of product and proof of concept.

2. Application of License Fees. All License fees are paid in full at the time of purchase.

3. Use of Advance License Fees. Advance license fees will be used for purposes including,
but not limited to, technology enhancements including web services, carrier services, card
services support, disclaimers, security and administrative rights, and regionalization
specific to the multi dwelling unit population.

 

 

 

[SIGNATURE PAGE]

This Agreement is entered into by the parties as of the Effective Date.

DATE: May 10, 2010

Technology Provider:

Robertson Technologies Licensing, LLC

	 	 	 	 	 
	By:

	 	/s/ Joel C. Robertson
 

	 	 
	 

	 	Dr. Joel Robertson	 	 
	 

	 	CEO	 	 
	 
	 	 	 	 
	Companies On Text, LLC:

LICENSEE	 	 
	 
	 	 	 	 
	By:

	 	/s/ Michael Brady
 

	 	 
	 

	 	Michael Brady	 	 
	 

	 	CEOExhibit 10.19

Exhibit 10.19

International Countries Addendum to Robertson Technologies

Licensing, Agreement with Companies On Text, L.L.C. Licensing

Agreement

As of 04/28/2010, the contract entitled Robertson Technologies Licensing, LLC And Companies On
Text, L.L.C., a contracted distributor of Aversien Science, LLC Licensing Agreement between
Robertson Technologies Licensing, LLC and Companies On Text, L.L.C. will be supplemented as
follows:

I. DISTRIBUTION RIGHTS will be added as follows:

Licensee has the right to sell Licensor solutions. Licensor has an inherit right to make
sales through its own organization and other contractual relationships as well. However, for the
purpose of distribution this will consist of direct to consumer markets in United Arab Emirates,
Australia, China, Saudi Arabia with Exclusivity, WHERE Licensee is granted exclusivity in this
space for a period of three (3) years provided the performance measures listed in XVIII are met.
If a sale is made by any other party in these markets utilizing the concept developed for these
markets, the sale must flow thru Licensee. Licensee will have the responsibility to facilitate the
implementation of the sales process as it does for its own direct customer. Licensee will have the
right to generate its mark up or profit margin for the customers brought by other parties, provided
the price point is consistent with the model developed and agreed upon.

II. PERFORMANCE MEASURES

Licensee Measures

Year 1 — Licensee is required to purchase a minimum of five million (5,000,000) licenses
from the Licensor. Licensee is granted a program implementation period of six (6) months
and program execution period of twelve (12) months for a total of eighteen (18) months.

Year 2 — Licensee is required to purchase a minimum of seven million (7,000,000) licenses
from the Licensor.

Year 3 — Licensee is required to purchase a minimum of nine million (9,000,000) licenses
from the Licensor.

Licensor Measures

Year 1 — Licensor is required to be able to provision five million (5,000,000) licenses.

Year 2 — Licensor is required to be able to provision seven million (7,000,000) licenses.

Year 3 — Licensor is required to be able to provision nine million (9,000,000) licenses.

At the end of the first 12 months licensor will review exclusivity performance and if required take
corrective action to get back on track.

 

 

 

III. SUPPORT Licensee shall receive the support of Licensor in its efforts to market Licensor
products/licenses. Aversien Science shall facilitate the support services on behalf of Licensor.
This includes making arrangements, where deemed appropriate for appearances at key events, attend
key meetings, endorsements (letters, video, audio, media’s, etc.). Licensor shall support
its business technology systems, deliverance of technology to consumer sector, and expertise in
handling technical questions. Licensor through Aversien Science shall provide training on its
products/licenses to Licensee and its agents/contractors. Once trained, Licensee may become a
technical implementation partner with Licensor with the capabilities of training all future
contractors, agents, distribution outlets, etc. This will be reviewed and is at the sole
discretion of Aversien Science and Licensor.

Any costs incurred by Licensee in the marketing and distribution of the Licensor Technology are the
sole responsibility of Licensee. Such costs include, but are not limited to, travel,
entertainment, printing and marketing, etc. Licensee may use certain logos and corporate partner
names in marketing materials and sales presentations as agreed upon. All marketing materials
developed for the purpose of selling to customers must be pre-approved by Aversien Science, L.L.C.
and Licensor before use. Licensor, Aversien Science, and Licensee agree to establish a marketing
material response process of seven (7) days or less for material approval. All press related
material will be coordinated and approved by Licensor and Aversien Science. Licenses purchased by
Licensee are one year renewable licenses and the end user has unlimited use of the general license
for one full year from time of purchase, at which time a payment is due to continue use of the
license.

IV. PAYMENTS.

	 	1.	 	License Fees. In consideration for the license and other rights granted to Licensee,
Licensee will pay Licensor license fees as follows:

	 	a.	 	Eight Dollars ($8.00) per license distributed through licensee.
License is for a one (1) year usage and is renewable annually at the same
Eight Dollar ($8.00) rate. However, Licensor and Aversien Science reserve the
right to adjust pricing according to business and market conditions at the end
of three-year contract from date of contract execution.

	 	2.	 	Application of License Fees. All License fees are paid in full at the time of purchase.

	 	3.	 	Exclusivity Rights Market Fees. The acquisition cost to the Licensee for the
exclusive rights to distribute Licensor technology in the above-mentioned markets is
One Million Dollars ($1,000,000) USD, and the pre purchase of three hundred
seventy-five thousand (375,000) licenses at Eight Dollars ($8.00) per license, payable
on or before 30 days following execution of this Agreement.

	 	4.	 	Platform Setup Fees. Platform Setup fees of One Million Two Hundred Fifty
Dollars ($1,250,000) USD are payable to the Licensor payable upon execution of this
Agreement. This will include one (1) major language per country.

 

 

 

[SIGNATURE PAGE]

This Amendment to the Agreement is entered into by the parties as of the Effective Date.

DATE: May 10, 2010

Technology Provider:

Robertson Technologies Licensing, LLC

	 	 	 	 	 
	By:

	 	/s/ Joel C. Robertson
 

	 	 
	 

	 	Dr. Joel Robertson	 	 
	 

	 	CEO	 	 
	 
	 	 	 	 
	Companies On Text: 

LICENSEE	 	 
	 
	 	 	 	 
	By:

	 	/s/ Michael Brady
 

	 	 
	 

	 	Michael Brady	 	 
	 

	 	CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}]]